U.S. President Donald Trump said on Saturday (May 23, 2026) a deal with Iran had been “largely negotiated,” with the proposal including opening the crucial Strait of Hormuz, though the agreement was “subject to finalisation.” “An Agreement has been largely negotiated
A person who approached a White House security checkpoint and began firing at officers has died, according to federal officials. The U.S. Secret Service said in a statement late on Saturday (May 23, 2026) that, according to a preliminary investigation
Pakistani woman says corporate culture makes employees feel guilty for taking leave: ‘Rest needs justification’A Pakistani woman said corporate jobs made employees feel guilty for taking paid leaves they were allowed to use. Published on: May 24
This crunchy veggie rice paper pancake is the perfect quick-fix snack for sudden hunger cravings at home: Full recipeFrom crispy edges to flavour-packed bites, try this veggie rice paper pancake recipe for an ultimate comfort snack for lazy evenings. Updated on: May 24
Amazon techie earning ₹11 lakh/month has 1 house in US, 4 properties in India, Range Rover — but no emergency fundAn Amazon employee earning close to $300,000 feels financially insecure despite significant savings and investments. Published on: May 24
Indian Pharma is ready to flex generics muscle as Ozempic, Wegovy patent expires
Indian Pharma is ready to flex generics muscle as Ozempic, Wegovy patent expires today
Indian Pharma is ready to flex generics muscle as Ozempic, Wegovy patent expires today
Sun Pharma to Dr Reddy's and Lupin are gearing up to launch over 50 brands that will compete with Ozempic, Wegovy and Mounjaro at half the price.
Published on: Mar 20, 2026 10:53 AM IST By HT Business Desk Share via Copy link India's pharma industry is ready to flex its generics muscle as the patent for a key ingredient of blockbuster weight-loss drugs expires today. Pharmarack estimates India’s weight-loss drug market to surge from roughly ₹1,500 crore today to ₹8,000 crore by 2030. (Reuters) More than 40 Indian drugmakers are gearing up to launch over 50 brands that'll compete with Ozempic and Wegovy at half the price. The impending supply glut is expected to democratise access in a notoriously price-sensitive market, while raising concerns over regulatory oversight and the potential for widespread drug misuse. The stakes are immense. India, the world’s most populous nation, carries the second-highest diabetic burden globally after China—450 million of us may be obese or overweight by 2050, according to The Lancet. Pharmarack estimates India’s obesity drug market will surge from roughly ₹1,500 crore today to ₹8,000 crore by 2030.Half-Price Ozempic, Wegovy, Mounjaro
India's generic drugmakers—globally renowned for their ability to manufacture low-cost medicines at scale—are preparing to aggressively undercut the market. Analysts project these generics will debut at steep discounts of at least 50% to 60% compared to branded counterparts like Novo Nordisk’s Wegovy and Ozempic, or Eli Lilly & Co.’s Mounjaro. Monthly costs for the lowest dose of semaglutide—the key active pharmaceutical ingredient (API) whose patent is expiring today—are expected to plummet from ~ ₹11,000 to a range of ₹3,000 to ₹5,000 almost immediately. As production scales, prices could eventually bottom out between ₹1,500 and ₹2,500. This sharp deflation is poised to radically expand the consumer base. "Onboarding of patients from lower economic strata may happen on branded generics," noted Sheetal Sapale, commercial vice president at Pharmarack, told Reuters, though she cautioned that corporate profitability will hinge heavily on maintaining pricing discipline amid the glut.Too Many Options
Industry heavyweights including Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin Ltd., Mankind Pharma, and Alkem Laboratories Ltd. are all jockeying for market share. Rather than engaging in solo price wars, some top-tier firms are leveraging strategic co-marketing pacts to consolidate distribution. In a major pre-emptive move earlier this week, Zydus Lifesciences Ltd. and Torrent Pharmaceuticals Ltd. struck a licensing agreement to co-market a semaglutide injection. Under the terms of the deal, Zydus Lifesciences will manufacture an innovative formulation—a 15 mg/3 ml pre-filled cartridge utilised with a reusable pen—while Torrent Pharma secures semi-exclusive rights to market the drug under the brand name Sembolic. The upfront licensing fee structure allows Zydus to monetise its manufacturing prowess while Torrent Pharma leverages its massive domestic field force in chronic therapies. While the influx of generics is a boon for affordability, healthcare analysts are sounding the alarm over the potential for a regulatory “Wild West”. Semaglutide remains a prescription-only medication, but pharmaceutical enforcement in India has historically been porous. “With high demand, falling prices and multiple brands, you may see direct pharmacy purchases, distributor-level leakages, or cosmetic or lifestyle use, especially in urban markets,” warned Salil Kallianpur, an independent pharma analyst, told Reuters. Such unstructured access, Kallianpur argues, could lead to poor dosage titration, unmanaged side effects, and eventually, forced regulatory tightening by the state.Survival of the Fittest
The immediate aftermath of the patent cliff will be chaotic. The market will be saturated with “sema”-branded derivatives, overwhelming prescribers with aggressive marketing campaigns and varying device quality. However, in India’s physician-driven pharmaceutical ecosystem, long-term success will rely on clinical trust rather than just rock-bottom pricing. Doctors acting as gatekeepers are expected to eventually consolidate their prescriptions around a handful of reliable players who can guarantee supply chain integrity and consistent patient outcomes. For the dozens of companies entering the fray today, the clock is already ticking. “Weaker players with poor quality and no differentiation will likely exit within two to three years,” Kallianpur said. ABOUT THE AUTHOR HT Business Desk The HT Business Desk provides comprehensive coverage of the Indian and global financial markets. Based in Mumbai and New Delhi, the team tracks everything from Sensex and Nifty movements to the latest from India Inc., trade deals, and macroeconomic policy. We aim to empower readers with timely, fact-checked news that clarifies the complexities of the business world.Read More Business News Stay updated with the latest Business News on Petrol Price, Gold Rate, Silver Rates, Diesel Prices along with Income Tax Calculator News / Business / Indian Pharma Is Ready To Flex Generics Muscle As Ozempic, Wegovy Patent Expires Today See LessIndia's pharma industry is ready to flex its generics muscle as the patent for a key ingredient of blockbuster weight-loss drugs expires today.
More than 40 Indian drugmakers are gearing up to launch over 50 brands that'll compete with Ozempic and Wegovy at half the price. The impending supply glut is expected to democratise access in a notoriously price-sensitive market, while raising concerns over regulatory oversight and the potential for widespread drug misuse.
The stakes are immense. India, the world’s most populous nation, carries the second-highest diabetic burden globally after China—450 million of us may be obese or overweight by 2050, according to The Lancet. Pharmarack estimates India’s obesity drug market will surge from roughly ₹1,500 crore today to ₹8,000 crore by 2030.
Monthly costs for the lowest dose of semaglutide—the key active pharmaceutical ingredient (API) whose patent is expiring today—are expected to plummet from ~ ₹11,000 to a range of ₹3,000 to ₹5,000 almost immediately. As production scales, prices could eventually bottom out between ₹1,500 and ₹2,500.
This sharp deflation is poised to radically expand the consumer base. "Onboarding of patients from lower economic strata may happen on branded generics," noted Sheetal Sapale, commercial vice president at Pharmarack, told Reuters, though she cautioned that corporate profitability will hinge heavily on maintaining pricing discipline amid the glut.
Rather than engaging in solo price wars, some top-tier firms are leveraging strategic co-marketing pacts to consolidate distribution. In a major pre-emptive move earlier this week, Zydus Lifesciences Ltd. and Torrent Pharmaceuticals Ltd. struck a licensing agreement to co-market a semaglutide injection.
Under the terms of the deal, Zydus Lifesciences will manufacture an innovative formulation—a 15 mg/3 ml pre-filled cartridge utilised with a reusable pen—while Torrent Pharma secures semi-exclusive rights to market the drug under the brand name Sembolic. The upfront licensing fee structure allows Zydus to monetise its manufacturing prowess while Torrent Pharma leverages its massive domestic field force in chronic therapies.
While the influx of generics is a boon for affordability, healthcare analysts are sounding the alarm over the potential for a regulatory “Wild West”. Semaglutide remains a prescription-only medication, but pharmaceutical enforcement in India has historically been porous.
“With high demand, falling prices and multiple brands, you may see direct pharmacy purchases, distributor-level leakages, or cosmetic or lifestyle use, especially in urban markets,” warned Salil Kallianpur, an independent pharma analyst, told Reuters.
Such unstructured access, Kallianpur argues, could lead to poor dosage titration, unmanaged side effects, and eventually, forced regulatory tightening by the state.
However, in India’s physician-driven pharmaceutical ecosystem, long-term success will rely on clinical trust rather than just rock-bottom pricing.
Doctors acting as gatekeepers are expected to eventually consolidate their prescriptions around a handful of reliable players who can guarantee supply chain integrity and consistent patient outcomes.
For the dozens of companies entering the fray today, the clock is already ticking. “Weaker players with poor quality and no differentiation will likely exit within two to three years,” Kallianpur said.
Source: HindustanTimes
Related Posts: Fenty Beauty in India is a flex Cross-Party Flex New ‘electronic ink’ could make gadgets bend and flex like never before Maruti Fronx Flex-Fuel SUV Revealed Ahead Of Global Debut - Details RCB Flex All-Round Muscle As Smriti Mandhana Praises Bowlers Post DC Clash Flex Engines Gaining Traction In India With Ethanol Push CBSE Class 11 YouTube Now Offers AI-Powered Search Feature For More Users But Not In India Siri’s Big Upgrade 3-Month CAT 2025 Preparation Plan
With big-budget spectacles and larger-than-life action becoming the norm, one upcoming Hindi film is now aiming for something Indian cinema has rarely explored in a full-fledged way… alien horror. Actor Akshay Kumar is set to headline Samuk, a sci-fi thriller centred around extraterrestrial
1 days ago
Kara OTT release: Dhanush's ₹50 crore heist film gets digital release in less than a month; when and where to watchKara OTT release: Vignesh Raja's Tamil film starring Dhanush and Mamitha Baiju was released in theatres on April 30. Know when and where to stream it online. May 24, 2026
1 days ago
The Supreme Court on Saturday registered a suo motu case in connection with the death of a woman in Madhya Pradesh, whose family has alleged that her in-laws harassed her for dowry, reported The Hindu. Chief Justice Surya Kant and Justices Joymalya Bagchi and Vipul Pancholi will hear the case on
1 days ago
Rare lung transplant at Apollo saves a life; spotlight on India's organ donor shortageRare lung transplant at Apollo saves a life; spotlight on India's organ donor shortage Published on: May 24, 2026 10:33 AM IST PTI Share via Copy link New Delhi, A year ago, every breath felt borrowed
1 days ago
Editorial independence is core to our work. Some links may earn us a commission, without influencing our opinions.These countertop organisers, crockery pick and jars can give your kitchen a Pinteresty spin by keeping the clutter awayTurn your kitchen into a photo-ready space with stylish organisers
1 days ago
Indian athletics witnessed a historic evening in Ranchi as Tejaswin Shankar became the first Indian ever to breach the 8000-point barrier in decathlon at the Federation Cup on Saturday. The 27-year-old produced a sensational all-round performance to finish with 8057 points
1 days ago
The Centre released draft rules for the Viksit Bharat – Guarantee for Rozgar and Ajeevika Mission (Gramin) Act, 2025 for public consultation. The rules focus on governance, grievance redressal, and transitioning from MGNREGA to the new rural employment scheme
1 days ago
The National Threat Analytics Unit of the Indian Cybercrime Coordination Centre (I4C) has warned of a sophisticated phishing campaign impersonating Apple tech support to target whose devices have been lost or stolen, officials said on Saturday.The I4C, which functions under the Union Home Ministry
1 days ago
Sachin Tendulkar praised his son Arjun's IPL debut for Lucknow Super Giants. Arjun Tendulkar showed patience and skill in his first match. He bowled well and took a wicket. Sachin Tendulkar expressed pride in his son's performance and attitude
1 days ago
White House shooting suspect claimed to be ‘real’ Osama bin Laden, threatened Trump online: ReportOsama bin Laden was the founder and leader of the terror group Al-Qaeda, which was reportedly responsible the 9/11 attacks. Updated on: May 24, 2026 11:02 AM IST By Anita Goswami Share via Copy
1 days ago
May 24, Birthday Horoscope: Here's what the tarot cards have in store for youIf your birthday falls on May 24, here’s what your year ahead looks like, as per Tarot. Published on: May 24, 2026 11:00 AM IST By Kishori Sud Share via Copy link If you were born on May 24
1 days ago
George Russell may have delivered the perfect answer to mounting pressure at Mercedes. After a fiery sprint race clash with championship-leading teammate Kimi Antonelli earlier on Saturday, the Briton bounced back in style to grab pole position for Sunday’s Canadian Grand Prix — edging the
1 days ago
BJP candidate Debangshu Panda is leading significantly in the Falta assembly constituency repoll. After five rounds of counting, Panda has secured a lead of over 14,000 votes against his CPI(M) rival. The repoll followed allegations of EVM tampering and irregularities during the initial polling
1 days ago
The suspect in a shooting near the White House was killed in an exchange of fire with Secret Service agents on Saturday evening, officials have confirmed. BBC's US media partner CBS has named the suspect as Nasire Best, a 21-year-old man who was known to the Secret Service and had a documented
1 days ago
CPI(M) MP raises concerns over CBSE's digital evaluation, seeks interventionCPI(M) MP raises concerns over CBSE's digital evaluation, seeks intervention Published on: May 23, 2026 5:22 PM IST PTI Share via Copy link New Delhi, The Rajya Sabha leader of the CPI, John Brittas
1 days ago
Imagine enjoying a decadent, fudge‑like treat that also supports your hormones, libido, and menstrual rhythm, all while being packed with collagen, magnesium, adaptogens, and lignan‑rich omega‑3s. These Seed Cycling Hormone Bliss Balls are designed around the simple yet powerful practice of
1 days ago
Weekly Love Horoscope for May 24-30, 2026: The stars brings positive energies for these zodiac signsWeekly Love Horoscope for May 24-30, 2026: This week asks for patience, trust, and emotional resilience. Published on: May 24, 2026 7:30 AM IST By Kishori Sud Share via Copy link Aries Love feels
1 days ago
From a darkly comic tale of revenge to a beautiful contemplation on friendship, here are the year's most acclaimed works of fiction so far. "Daring, deranged, cleverly written," is how Vogue describes the buzzy debut by Caro Claire Burke. In this satirical thriller
1 days ago
Overnight fires in Delhi: Shops, homes gutted in four blazesA fire department officer was injured after the tin shed of one of the shops he was standing on during the firefighting operation collapsed. Updated on: May 24, 2026 7:37 AM IST By Karn Pratap Singh Share via Copy link Four separate fire
1 days ago
As per the government, the new rules enable families living in Delhi to submit applications if their annual household income is within the newly prescribed limit. New Delhi: The Delhi government has reopened the process of issuing fresh ration cards under changed eligibility criteria after a gap of
1 days ago
The reported disruption of AI-animated film Critterz after OpenAI allegedly shut down Sora has sparked a larger conversation around one major issue in tech and entertainment: what happens when creators build entire projects on platforms they do not control?The reported disruption of AI-animated
1 days ago
Ex-Meta employee says non-Chinese workers were targeted for layoffsA laid-off Meta engineer has alleged that he was routinely excluded and ostracised by his Chinese colleagues at the company. Updated on: May 24, 2026 7:01 AM IST By Sanya Jain Share via Copy link A laid-off Meta engineer has alleged
1 days ago
Mackenzie Shirilla wanted Kim Kardashian's help; here's why it's not happeningMackenzie Shirilla sought Kim Kardashian's legal support following the release of The Crash documentary, but Kardashian reportedly has no plans to get involved. May 24, 2026
1 days ago
X warns founder against reuploading White House shooting video: 'Revenue reduced by 90%'Nikita Bier of X warned a user against reuploading the White House shooting video, asking him to ‘Quote’ or ‘Video Reshare’ instead. Updated on: May 24, 2026 6:14 AM IST By Sanya Jain Share via Copy link
1 days ago
Sonam Wangchuk says Article 371 talks for Ladakh still ‘work in progress’; backs Cockroach Janta PartySonam Wangchuk hoped constitutional safeguards will be granted to Ladakh after recent talks between Ladakh groups and the Centre. Updated on: May 24
1 days ago
Talking about international partnerships, PM Modi said India’s growing ties with global companies and countries would create new opportunities for young people. Prime Minister Narendra Modi distributed more than 51,000 appointment letters to newly recruited candidates during the 19th Rozgar Mela
1 days ago
Dipika Kakar’s father-in-law in ICU after suffering stroke, Shoaib Ibrahim seeks prayers: ‘24 hrs are crucial’Shoaib Ibrahim took to Instagram to inform fans that his father has been hospitalised once again after suffering another stroke. May 24, 2026
1 days ago
